Tumor Angiogenic and Hypoxic Profiles Predict Radiographic Response and Survival in Malignant Astrocytoma Patients Treated With Bevacizumab and Irinotecan

PURPOSE: The combination of a vascular endothelial growth factor (VEGF) -neutralizing antibody, bevaci-zumab, and irinotecan is associated with high radiographic response rates and improved survival outcomes in patients with recurrent malignant gliomas. The aim of these retrospective studies was to...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Sathornsumetee, Sith, Cao, Yiting, Marcello, Jennifer E., Herndon, James E., McLendon, Roger E., Desjardins, Annick, Friedman, Henry S., Dewhirst, Mark W., Vredenburgh, James J., Rich, Jeremy N.
Format: Artigo
Sprog:Inglês
Udgivet: 2008
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3930173/
https://ncbi.nlm.nih.gov/pubmed/18182667
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2007.13.3652
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker